Evidence map›Paper›PMID 25399785›Full record

ArticleJournal of biomedical materials research. Part B, Applied biomaterials2015

Multifunctional spider silk polymers for gene delivery to human mesenchymal stem cells.

Olena S Tokareva, Dean L Glettig, Rosalyn D Abbott, David L Kaplan

Abstract read
In one paragraph

Article in Journal of biomedical materials research. Part B, Applied biomaterials, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Olena S TokarevaDepartment of Biomedical Engineering, Tufts University, Medford, Massachusetts, 02155.
Dean L GlettigDepartment of Biomedical Engineering, Tufts University, Medford, Massachusetts, 02155.
Rosalyn D AbbottDepartment of Biomedical Engineering, Tufts University, Medford, Massachusetts, 02155.
David L KaplanDepartment of Biomedical Engineering, Tufts University, Medford, Massachusetts, 02155.
Tufts University · US

Funding

Translational Bioreactors - Engineering Complex TissuesP41EB002520 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2004 to 2018
$16.7M
Integration of Biopolymer Design and Modeling: Silk Gene Delivery SystemsF32EB018138 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI TOKAREVA, OLENA S · 2014 to 2014
$59k
NIBIB NIH HHS 1F32 EB018138-01NIBIB NIH HHS F32 EB018138NIBIB NIH HHS P41 EB002520
6 · The paper itself

Abstract

Non-viral gene delivery systems are important transport vehicles that can be safe and effective alternatives to currently available viral systems. A new family of multifunctional spider silk-based gene carriers was bioengineered and found capable of targeting human mesenchymal stem cells (hMSCs). These carriers successfully delivered DNA to the nucleus of these mammalian cells. The presence of specific functional sequences in the recombinant proteins, such as a nuclear localization sequence (NLS) of the large tumor (T) antigen of the Simian virus 40 (SV40 ), an hMSC high affinity binding peptide (HAB), and a translocation motif (TLM) of the hepatitis-B virus surface protein (PreS2), and their roles in mitigation and enhancement of gene transfection efficiency towards hMSCs were characterized. The results demonstrate that these bioengineered spider silk proteins serve as effective carriers, without the well-known complications associated with viral delivery systems.

Indexed as

Gene Transfer TechniquesAnimalsHumansMesenchymal Stem CellsSilkSpidersSilkhuman mesenchymal stem cellsnon-viral gene deliverynuclear targetingrecombinant DNA technologyspider silks

Identifiers

PMID25399785
PMCPMC4433878
OpenAlexW2155675812

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.